Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis

被引:104
|
作者
Kazmi, Farasat [1 ]
Soon, Yu Yang [1 ]
Leong, Yiat Horng [1 ]
Koh, Wee Yao [1 ]
Vellayappan, Balamurugan [1 ,2 ]
机构
[1] Natl Univ Singapore Hosp, Natl Univ Canc Inst Singapore, Dept Radiat Oncol, Singapore 119228, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, 10 Med Dr, Singapore 117597, Singapore
关键词
Recurrence; Glioblastoma multiforme; Re-irradiation; Stereotactic radiosurgery; Brachytherapy; FRACTIONATED STEREOTACTIC REIRRADIATION; SALVAGE TREATMENT; RADIATION-THERAPY; MALIGNANT GLIOMAS; PHASE-II; RADIOSURGERY; MULTIFORME; BRACHYTHERAPY; RADIOTHERAPY; BEVACIZUMAB;
D O I
10.1007/s11060-018-03064-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the efficacy and toxicity of re-irradiation for patients with recurrent GBM. We searched various biomedical databases from 1998 to 2018, for eligible studies where patients were treated with re-irradiation for recurrent GBM. Outcomes of interest were 6 and 12-month overall survival (OS-6, OS-12), 6 and 12-month progression free survival (PFS-6, PFS-12) and serious (Grade 3 +) adverse events (AE). We used the random effects model to pool outcomes across studies and compared pre-defined subgroups using interaction test. Methodological quality of each study was assessed using the Newcastle-Ottawa scoring system. We found 50 eligible non-comparative studies including 2095 patients. Of these, 42% were of good or fair quality. The pooled results were as follows: OS-6 rate 73% (95% confidence interval (CI) 69-77%), OS-12 rate 36% (95% CI 32-40%), PFS-6 rate 43% (95% CI 35-50%), PFS-12 rate 17% (95% CI 13-20%), and Grade 3 + AE rate 7% (95% CI 4-10%). Subgroup analysis showed that prospective studies reported higher toxicity rates, and studies which utilized brachytherapy to have a longer OS-12. Within the external beam radiotherapy group, there was no dose-response [above or below 36 Gy in 2 Gy equivalent doses (EQD2)]. However, a short fractionation regimen (ae<currency> 5 fractions) seemed to provide superior PFS-6. The available evidence, albeit mostly level III, suggests that re-irradiation provides encouraging disease control and survival rates. Toxicity was not uniformly reported, but seemed to be low from the included studies. Randomized controlled trials (RCT) are needed to establish the optimal management strategy for recurrent GBM.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 50 条
  • [1] Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
    Farasat Kazmi
    Yu Yang Soon
    Yiat Horng Leong
    Wee Yao Koh
    Balamurugan Vellayappan
    [J]. Journal of Neuro-Oncology, 2019, 142 : 79 - 90
  • [2] Re-Irradiation for Recurrent Glioblastoma Multiforme (GBM) : Systematic Review and Meta-Analysis
    Vellayappan, B.
    Kazmi, F.
    Lim, K. H. C.
    Yeo, T. T.
    Wong, A.
    Soon, Y. Y.
    Koh, W. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E114 - E114
  • [3] Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis
    Luo, Tingfan
    Feng, Jin
    Sun, Pengfei
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 229
  • [4] Re-Irradiation Using Brachytherapy for Recurrent Intracranial Tumors: A Systematic Review and Meta-Analysis of the Literature
    Choi, Mehee
    Zabramski, Joseph M.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [5] RE-IRRADIATION FOR RECURRENT GLIOBLASTOMAS (GBM)
    Moro, Mario
    [J]. NEURO-ONCOLOGY, 2020, 22 : 186 - 186
  • [6] Re-irradiation with hyperthermia for loco-regional recurrent breast cancer: A systematic review and meta-analysis
    Datta, N. R.
    Puric, E.
    Klingbiel, D.
    Bodis, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S333 - S333
  • [7] A systematic review and meta-analysis for re-irradiation with hyperthermia for loco-regional recurrent breast cancers
    Datta, N. R.
    Puric, E.
    Klingbiel, D.
    Bodis, S.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (11) : 900 - 901
  • [8] Re-Irradiation for Recurrent Glioblastoma Multiforme
    Rades, Dirk
    Witteler, Jaspar
    Leppert, Jan
    Schild, Steven E.
    [J]. ANTICANCER RESEARCH, 2020, 40 (12) : 7077 - 7081
  • [9] Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme
    Torok, J. A.
    Wegner, R. E.
    Mintz, A. H.
    Heron, D. E.
    Burton, S. A.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2011, 10 (03) : 253 - 258
  • [10] Bevacizumab combined with re-irradiation in recurrent glioblastoma
    She, Lei
    Su, Lin
    Liu, Chao
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12